These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6242777)

  • 21. Morphological findings in placentae of insulin-dependent diabetic patients treated with continuous subcutaneous insulin infusion (CSII).
    Laurini RN; Visser GH; van Ballegooie E; Schoots CJ
    Placenta; 1987; 8(2):153-65. PubMed ID: 3615374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
    Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
    Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion.
    Peden NR; Braaten JT; McKendry JB
    Diabetes Care; 1984; 7(1):1-5. PubMed ID: 6423352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics.
    Felsing W; Bibergeil H; Menzel R; Albrecht G; Felsing U; Dabels J; Reichel G; Lüder C
    Exp Clin Endocrinol; 1984 Apr; 83(2):136-42. PubMed ID: 6373315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
    Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
    Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study.
    Drever E; Tomlinson G; Bai AD; Feig DS
    Diabet Med; 2016 Sep; 33(9):1253-9. PubMed ID: 26927202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous subcutaneous insulin infusion therapy (CSII) influences cardiovascular responses to graded exercise in patients with autonomic diabetic neuropathy of the cardiovascular system (ADNCS).
    Sachse G; Neuzner J; Mäser E; Federlin K
    Life Support Syst; 1985; 3 Suppl 1():530-4. PubMed ID: 3870617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrapartum management of insulin-dependent diabetes mellitus (IDDM) gestants. A comparative study of constant intravenous insulin infusion and continuous subcutaneous insulin infusion pump (CSIIP).
    Feldberg D; Dicker D; Samuel N; Peleg D; Karp M; Goldman JA
    Acta Obstet Gynecol Scand; 1988; 67(4):333-8. PubMed ID: 3051881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mismanagement of infusion pumps.
    Sonnenberg GE; Chantelau E; Berger M
    Diabetes Care; 1982; 5(2):145. PubMed ID: 6927726
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical outcomes of adult inpatients treated with continuous subcutaneous insulin infusion for diabetes mellitus: a systematic review.
    Anstey J; Yassaee A; Solomon A
    Diabet Med; 2015 Oct; 32(10):1279-88. PubMed ID: 25763540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study.
    Giménez M; Conget I; Nicolau J; Pericot A; Levy I
    Acta Diabetol; 2007 Mar; 44(1):34-7. PubMed ID: 17357884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocturnal hypoglycemia in patients treated with continuous subcutaneous insulin infusion.
    Cohen CD
    Am J Obstet Gynecol; 1988 Aug; 159(2):536-7. PubMed ID: 3407716
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin resistance and insulin-dependent diabetes mellitus.
    Pedersen O; Beck-Nielsen H
    Diabetes Care; 1987; 10(4):516-23. PubMed ID: 3113899
    [No Abstract]   [Full Text] [Related]  

  • 38. Preconceptional diabetes control in insulin-dependent diabetes mellitus patients with continuous subcutaneous insulin infusion therapy.
    Dicker D; Feldberg D; Karp M; Yeshaya A; Samuel N; Goldman JA
    J Perinat Med; 1987; 15(2):161-7. PubMed ID: 3656048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
    González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F
    Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal eyes in type 1 diabetics stay normal after one year of treatment with continuous subcutaneous insulin pump.
    Agardh E; Bauer B; Tallroth G; Agardh CD
    Acta Ophthalmol (Copenh); 1986 Oct; 64(5):530-2. PubMed ID: 3544667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.